An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman diseaseTomohiro Koga,Sachiko Takemori,Naoko Hagimori,Shimpei Morimoto,Remi Sumiyoshi,Toshimasa Shimizu,Naoki Hosogaya,Chizu Fukushima,Hiroshi Yamamoto,Atsushi KawakamiMedicine(2020)引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要